Literature DB >> 10992451

Generation of female genital tract antibody responses by local or central (common) mucosal immunization.

H Y Wu1, S Abdu, D Stinson, M W Russell.   

Abstract

Genital antibody responses were compared in female mice immunized intravaginally (i.vag.) or intranasally (i.n.) with a bacterial protein antigen (AgI/II of Streptococcus mutans) coupled to the B subunit of cholera toxin. Serum and salivary antibodies were also evaluated as measures of disseminated mucosal and systemic responses. Although i.vag. immunization induced local vaginal immunoglobulin A (IgA) and IgG antibody responses, these were not disseminated to a remote secretion, the saliva, and only modest levels of serum antibodies were generated. In contrast, i.n. immunization was substantially more effective at inducing IgA and IgG antibody responses in the genital tract and in the circulation, as well as at inducing IgA antibodies in the saliva. Moreover, mucosal and systemic antibodies induced by i.n. immunization persisted for at least 12 months. Analysis of the molecular form of genital IgA indicated that the majority of both total IgA and specific IgA antibody was polymeric, and likely derived from the common mucosal immune system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992451      PMCID: PMC101503          DOI: 10.1128/IAI.68.10.5539-5545.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.

Authors:  G Hajishengallis; S K Hollingshead; T Koga; M W Russell
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

2.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

3.  Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration.

Authors:  M D Lubeck; R J Natuk; M Chengalvala; P K Chanda; K K Murthy; S Murthy; S Mizutani; S G Lee; M S Wade; B M Bhat
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

4.  Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle.

Authors:  F X Lü; Z Ma; T Rourke; S Srinivasan; M McChesney; C J Miller
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 5.  Mucosal immunity in the female genital tract.

Authors:  P Brandtzaeg
Journal:  J Reprod Immunol       Date:  1997-11-30       Impact factor: 4.054

6.  Secretory immunity in the female reproductive tract.

Authors:  W H Kutteh; J Mestecky
Journal:  Am J Reprod Immunol       Date:  1994-01       Impact factor: 3.886

7.  Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.

Authors:  A C Menge; S M Michalek; M W Russell; J Mestecky
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Urethral glands of the male mouse contain secretory component and immunoglobulin A plasma cells and are targets of testosterone.

Authors:  M B Parr; H P Ren; L D Russell; G S Prins; E L Parr
Journal:  Biol Reprod       Date:  1992-12       Impact factor: 4.285

9.  Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium.

Authors:  L A Hussain; C G Kelly; R Fellowes; E M Hecht; J Wilson; M Chapman; T Lehner
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

10.  Human urethral epithelium: immunohistochemical demonstration of secretory IgA.

Authors:  M T Perra; F Turno; P Sirigu
Journal:  Arch Androl       Date:  1994 May-Jun
View more
  17 in total

Review 1.  Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

Authors:  C N Cornelissen
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

2.  Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1.

Authors:  Teena Mohan; D Mitra; D N Rao
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

3.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

4.  Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavity.

Authors:  Elizabeth S DeLyria; Dapeng Zhou; Jun Soo Lee; Shailbala Singh; Wei Song; Fenge Li; Qing Sun; Hongzhou Lu; Jinhui Wu; Qian Qiao; Yiqiao Hu; Guodong Zhang; Chun Li; K Jagannadha Sastry; Haifa Shen
Journal:  Carbohydr Res       Date:  2014-12-03       Impact factor: 2.104

5.  Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.

Authors:  Ryan G Gaudet; Felix Breden; Frank Plummer; Jody D Berry
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

6.  Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.

Authors:  Gregory A Price; Michael W Russell; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

7.  Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins.

Authors:  Diana I Albu; Agnes Jones-Trower; Amy M Woron; Kathleen Stellrecht; Christopher C Broder; Dennis W Metzger
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 8.  Dendritic cells and vaccine design for sexually-transmitted diseases.

Authors:  Dorothee Duluc; Julien Gannevat; Hyemee Joo; Ling Ni; Katherine Upchurch; Muriel Boreham; Michael Carley; Jack Stecher; Gerard Zurawski; Sangkon Oh
Journal:  Microb Pathog       Date:  2012-11-29       Impact factor: 3.738

9.  Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections.

Authors:  Charles W Armitage; Connor P O'Meara; Marina C G Harvie; Peter Timms; Odilia L Wijburg; Kenneth W Beagley
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

10.  Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus.

Authors:  Bruno Garulli; Yoshihiro Kawaoka; Maria R Castrucci
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.